Publicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (17)

2024

  1. Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents

    Biomedicine and Pharmacotherapy, Vol. 173

  2. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

    Clinical and Translational Oncology

2022

  1. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

2021

  1. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

    npj Precision Oncology, Vol. 5, Núm. 1

2020

  1. Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer

    Cells, Vol. 9, Núm. 2

  2. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

2018

  1. ARole forCXCR4in peritonealandhematogenous ovarian cancer dissemination

    Molecular Cancer Therapeutics, Vol. 17, Núm. 2, pp. 532-543

2017

  1. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

    International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563

  2. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology, Vol. 30, Núm. 1, pp. 134-145

  3. Obesity and menopause modify the epigenomic profile of breast cancer

    Endocrine-related cancer, Vol. 24, Núm. 7, pp. 351-363

  4. Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling

    Nature Communications, Vol. 8, Núm. 1

2016

  1. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

    The Lancet Oncology, Vol. 17, Núm. 10, pp. 1386-1395

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2013

  1. Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial

    Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453

2009

  1. An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis

    International Journal of Cancer, Vol. 125, Núm. 2, pp. 257-263

2007

  1. APC Inactivation Associates With Abnormal Mitosis Completion and Concomitant BUB1B/MAD2L1 Up-Regulation

    Gastroenterology, Vol. 132, Núm. 7, pp. 2448-2458